HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Kaneda Selected Research

Neoplasm Metastasis (Metastasis)

11/2013Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application.
6/2001Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
6/2000Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes.
5/2000Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Kaneda Research Topics

Disease

33Neoplasms (Cancer)
11/2013 - 01/2000
11Hyperplasia
01/2004 - 02/2000
10Inflammation (Inflammations)
04/2006 - 08/2000
8Ischemia
03/2002 - 07/2000
6Melanoma (Melanoma, Malignant)
11/2013 - 06/2000
6Schizophrenia (Dementia Praecox)
01/2005 - 02/2000
6Vascular System Injuries
01/2004 - 04/2000
5Body Weight (Weight, Body)
01/2011 - 11/2000
5Reperfusion Injury
06/2009 - 07/2000
5Peripheral Arterial Disease
03/2002 - 02/2001
5Cardiovascular Diseases (Cardiovascular Disease)
12/2001 - 05/2000
5Sarcoma (Soft Tissue Sarcoma)
10/2001 - 05/2000
5Arteriosclerosis
10/2000 - 02/2000
4Neoplasm Metastasis (Metastasis)
11/2013 - 05/2000
4Fibrosis (Cirrhosis)
01/2004 - 08/2000
3Hypoxia (Hypoxemia)
03/2008 - 05/2001
3Hepatocellular Carcinoma (Hepatoma)
11/2005 - 01/2001
3Lung Neoplasms (Lung Cancer)
10/2003 - 03/2000
3Colonic Neoplasms (Colon Cancer)
06/2003 - 09/2001
3Atherosclerosis
11/2001 - 09/2000
3Myocardial Ischemia (Ischemic Heart Diseases)
08/2001 - 01/2000
3Carcinoma (Carcinomatosis)
07/2001 - 11/2000
3Cicatrix (Scar)
05/2001 - 07/2000
2Tuberculosis (Tuberculoses)
01/2011 - 01/2010
2Extensively Drug-Resistant Tuberculosis
01/2011 - 01/2010
2Osteoporosis
08/2010 - 06/2006
2Breast Neoplasms (Breast Cancer)
05/2007 - 12/2000
2Abdominal Aortic Aneurysm
04/2006 - 07/2005
2Atopic Dermatitis (Atopic Eczema)
12/2004 - 09/2002
2Hemorrhage
10/2003 - 07/2003
2Gynecomastia
02/2002 - 03/2001
2Anxiety Disorders (Anxiety Disorder)
02/2002 - 08/2001
2Vascular Diseases (Vascular Disease)
11/2001 - 06/2001
2Body Weight Changes
10/2001 - 03/2001
2Infarction (Infarctions)
09/2001 - 09/2001
2Necrosis
09/2001 - 07/2000
2Myocardial Infarction
09/2001 - 01/2000
2Serotonin Syndrome (Syndrome, Serotonin)
08/2001 - 03/2001
2Emphysema
01/2001 - 01/2000
2Choroidal Neovascularization
12/2000 - 02/2000

Drug/Important Bio-Agent (IBA)

24Liposomes (Liposome)IBA
01/2011 - 02/2000
12OligodeoxyribonucleotidesIBA
06/2006 - 02/2000
11NF-kappa B (NF-kB)IBA
06/2009 - 08/2000
10Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2006 - 05/2000
8DNA (Deoxyribonucleic Acid)IBA
01/2010 - 09/2000
8ElementsIBA
12/2004 - 07/2000
7Proteins (Proteins, Gene)FDA Link
12/2009 - 03/2000
7CytokinesIBA
06/2009 - 02/2000
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2006 - 01/2000
7Transcription Factors (Transcription Factor)IBA
04/2006 - 07/2000
6OligonucleotidesIBA
04/2006 - 07/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2001 - 02/2000
5Pharmaceutical PreparationsIBA
01/2011 - 06/2000
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2001 - 01/2000
4DNA VaccinesIBA
01/2011 - 03/2001
4Thymidine KinaseIBA
11/2005 - 12/2000
4LuciferasesIBA
11/2005 - 06/2000
4Messenger RNA (mRNA)IBA
01/2004 - 08/2000
4Antipsychotic Agents (Antipsychotics)IBA
02/2002 - 02/2000
4PlatinumIBA
10/2001 - 11/2000
4MethylcholanthreneIBA
10/2001 - 11/2000
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2011 - 12/2000
3Complementary DNA (cDNA)IBA
01/2004 - 06/2000
3Cisplatin (Platino)FDA LinkGeneric
10/2001 - 11/2000
3tandospironeIBA
08/2001 - 03/2001
3DecorinIBA
05/2001 - 07/2000
2Small Interfering RNA (siRNA)IBA
07/2012 - 12/2009
2VaccinesIBA
01/2011 - 01/2010
2Interleukin-12 (IL 12)IBA
01/2011 - 01/2010
2prostacyclin synthetase (prostacyclin synthase)IBA
08/2006 - 10/2000
2Ganciclovir (Cytovene)FDA LinkGeneric
11/2005 - 01/2001
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2004 - 11/2001
2Angiotensin IIIBA
06/2004 - 02/2000
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2004 - 05/2000
2Risperidone (Risperdal Consta)FDA LinkGeneric
12/2001 - 03/2001
2Cardiovascular AgentsIBA
12/2001 - 07/2000
2Hormones (Hormone)IBA
12/2001 - 07/2001
2Fluorescein (Funduscein)FDA LinkGeneric
10/2001 - 12/2000
2DigitoninIBA
10/2001 - 01/2001
2Serotonin (5 Hydroxytryptamine)IBA
08/2001 - 07/2001
2AntioxidantsIBA
07/2001 - 06/2001
2Phosphotransferases (Kinase)IBA
06/2001 - 05/2000
2NF-kappaB decoyIBA
06/2001 - 08/2000
2Trazodone (Trittico)FDA LinkGeneric
03/2001 - 01/2001
2Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2000 - 11/2000
2Transforming Growth Factor beta (TGF-beta)IBA
11/2000 - 09/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2000 - 08/2000
2CollagenIBA
10/2000 - 07/2000

Therapy/Procedure

20Therapeutics
12/2009 - 05/2000
5Drug Therapy (Chemotherapy)
07/2012 - 05/2000
4Injections
07/2012 - 01/2001
3Aftercare (After-Treatment)
12/2009 - 03/2001
3Thoracotomy
10/2003 - 01/2000
3Pneumonectomy (Lung Volume Reduction)
10/2001 - 01/2001
2Liver Transplantation
04/2014 - 06/2009
2Intraperitoneal Injections
07/2012 - 06/2000
2Immunotherapy
05/2007 - 11/2001
2Catheters
02/2003 - 04/2002
2Intramuscular Injections
11/2001 - 02/2001
2Lasers (Laser)
12/2000 - 02/2000